INSMED INSM
INSMED reports Q3 2026 results
Item 2.02 Reports results
- Form
- 8-K
- Filed
- Importance
- Major
- Accession
- 0001140361-26-041097
- Exhibit 99.1 includes press release
- Exhibit 99.2 includes presentation
Written from the 8-K on EDGAR. Check the filing before you rely on it.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Biogen BIIB public float $18.4B, Jun 30, 2025
- Teva Pharmaceutical Industries TEVA public float $18.2B, Jun 30, 2025
- BeOne Medicines ONC public float $14.7B, Jun 30, 2025
- United Therapeutics UTHR public float $11.2B, Jun 30, 2025
- Alnylam Pharmaceuticals ALNY public float $42.6B, Jun 30, 2025